Guided Therapeutics (GTHP) Debt Ratio (2016 - 2025)
Historic Debt Ratio for Guided Therapeutics (GTHP) over the last 14 years, with Q3 2025 value amounting to 0.12.
- Guided Therapeutics' Debt Ratio fell 8737.26% to 0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12, marking a year-over-year decrease of 8737.26%. This contributed to the annual value of 0.12 for FY2024, which is N/A changed from last year.
- Guided Therapeutics' Debt Ratio amounted to 0.12 in Q3 2025, which was down 8737.26% from 0.1 recorded in Q2 2025.
- In the past 5 years, Guided Therapeutics' Debt Ratio registered a high of 0.95 during Q2 2024, and its lowest value of 0.03 during Q4 2022.
- Its 4-year average for Debt Ratio is 0.33, with a median of 0.28 in 2022.
- Within the past 5 years, the most significant YoY rise in Guided Therapeutics' Debt Ratio was 1097.28% (2022), while the steepest drop was 9108.73% (2022).
- Guided Therapeutics' Debt Ratio (Quarter) stood at 0.33 in 2021, then crashed by 91.09% to 0.03 in 2022, then surged by 303.04% to 0.12 in 2024, then decreased by 0.11% to 0.12 in 2025.
- Its last three reported values are 0.12 in Q3 2025, 0.1 for Q2 2025, and 0.11 during Q1 2025.